眶脂肪切除联合提上睑肌延长术治疗甲状腺相关眼病  

Lengthening of the levator muscle combined with orbital fat removal in treatment thyroid-associated ophthalmopathy

作　　者：胡超雄[1] 何夏怡[1] 杜庆生[1] 何晓雷[1] 余青松[1] 

机构地区：[1]广东省肇庆医学高等专科学校附属医院眼科中心,肇庆526020

出　　处：《中国实用眼科杂志》2006年第7期740-741,共2页Chinese Journal of Practical Ophthalmology

摘　　要：目的探讨眶脂肪切除联合提上睑肌延长术治疗甲状腺相关眼病的疗效。方法14例(21眼)经眼睑和结膜切口入路,切除肌肉圆锥内、外的脂肪联合提上睑肌延长术,达到降低眶压、减少眼球突出度和角膜暴露,改善容貌的目的。结果切除眶脂肪2.5～9.5ml,平均3.6ml,矫正眼球突出度2～6mm,平均3.0mm。提上睑肌延长5～10mm,平均7.6mm,矫正上睑退缩2.5～5mm,平均3.8mm。该治疗副作用少,不影响视力及眼球运动。结论眶脂肪切联合提上睑肌延长术可以缓解眼球突出和达到美容的效果,对保守治疗无效的甲状腺相关眼病是一种安全、有效,并发病少的治疗手段。Objective To study the lengthening of the levator muscle combined with orbital fat remoral in treatmant thyroid-associated opthalmopathy （TAO）. Methods 21 eyes of 14 patients with TAO, who transseptal excision of extraconal and intraconal fat were done through conjunctive or eyelid blepharoplasty approach, combined with lengthening of the levator muscle. Results Mean excision of 3.6 ml （range 2.5,-9.5 ml） of orbital fat reduced proptosis on average by 3.0mm （range 2-6mm）. Mean lengthening 7.6mm （range 5-10mm） of levator muscle corrected shrink on average by 3.8mm （range 2.5-5mm）. Side effeets were few. There was no significant effect in visual acuity and ocular motility. Conclusions Lengthening of the levator musch combined with orbital fat removal seems an effective and safe surgery for the treatment of patients with ATO.

关 键 词：眶脂肪切除术 提上睑肌延长术 甲状腺相关眼病 

分 类 号：R777.16[医药卫生—眼科] R771.3[医药卫生—临床医学]